Cargando…
Gluten-Free Diet in Childhood Difficult-to-Treat Nephrotic Syndrome: A Pilot Feasibility Study
INTRODUCTION: Minimal change disease in childhood can follow a frequently relapsing or steroid-dependent course in up to 40% of cases. Second-line immunosuppressive medications that are used to manage these patients are associated with significant adverse effects. There is a need for safer alternati...
Autores principales: | Srivastava, Tarak, Dell, Katherine M., Lemley, Kevin V., Gipson, Debbie S., Kaskel, Frederick J., Meyers, Kevin Edward, Faul, Christian, Goldhaber, Ayelet, Pehrson, LauraJane, Trachtman, Howard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936750/ https://www.ncbi.nlm.nih.gov/pubmed/36817288 http://dx.doi.org/10.1159/000525587 |
Ejemplares similares
-
Plasma Zonulin Levels in Childhood Nephrotic Syndrome
por: Trachtman, Howard, et al.
Publicado: (2019) -
Text Messaging for Disease Monitoring in Childhood Nephrotic Syndrome
por: Wang, Chia-shi, et al.
Publicado: (2019) -
Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children With Nephrotic Syndrome
por: Gipson, Debbie S., et al.
Publicado: (2019) -
Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET)
por: Komers, Radko, et al.
Publicado: (2017) -
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multi-disciplinary approach
por: Gadegbeku, Crystal A., et al.
Publicado: (2013)